ARS Pharmaceuticals, Inc. (SPRY)
(Real Time Quote from BATS)
$13.56 USD
+0.02 (0.15%)
Updated Aug 16, 2024 01:10 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.18 |
EPS Last Quarter | -0.13 |
Last EPS Surprise | -8.33% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.66 |
Next Year | -0.67 |
EPS (TTM) | -0.47 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.00M | 3.54M | 4.71M | 51.04M |
# of Estimates | 1 | 3 | 3 | 3 |
High Estimate | 2.00M | 8.10M | 8.60M | 63.70M |
Low Estimate | 2.00M | 0.70M | 2.33M | 33.42M |
Year ago Sales | 0.00M | 0.00M | 0.03M | 4.71M |
Year over Year Growth Est. | NA | NA | 15,605.24% | 983.72% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.18 | -0.25 | -0.66 | -0.67 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.17 | -0.27 | -0.64 | -0.71 |
High Estimate | -0.17 | -0.19 | -0.60 | -0.60 |
Low Estimate | -0.19 | -0.28 | -0.71 | -0.77 |
Year ago EPS | -0.16 | -0.07 | -0.57 | -0.66 |
Year over Year Growth Est. | -12.50% | -257.14% | -15.79% | -1.01% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 1 | 0 | 1 | 1 |
Down Last 7 Days | 1 | 1 | 2 | 1 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.18 | -0.25 | -0.66 | -0.67 |
7 Days Ago | -0.17 | -0.23 | -0.63 | -0.60 |
30 Days Ago | -0.19 | -0.23 | -0.65 | -0.63 |
60 Days Ago | -0.19 | -0.23 | -0.65 | -0.63 |
90 Days Ago | -0.19 | -0.23 | -0.72 | -0.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.18 | -0.23 | -0.66 | -0.71 |
Zacks Consensus Estimate | -0.18 | -0.25 | -0.66 | -0.67 |
Earnings ESP | 0.00% | 6.76% | 0.00% | -5.22% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.13 | -0.11 | -0.07 | -0.16 | NA |
Estimate | -0.12 | -0.11 | -0.14 | -0.18 | NA |
Difference | -0.01 | 0.00 | 0.07 | 0.02 | 0.02 |
Surprise | -8.33% | 0.00% | 50.00% | 11.11% | 13.20% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more